Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

Summary: Omalizumab, a recombinant DNA-derived humanized monoclonal antibody, binds to the Cε3 domain of immunoglobulin E (IgE) and forms complexes that inhibit the immune system's response to ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Advancements in Gene Editing Technology and Expansion of Oncology Research to Expand Demand for Humanized Mice ModelsRockville, MD, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The humanized mice model market is ...

Equities researchers at StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the stock ...

Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

Through its microfluidics technology, AbCellera can efficiently screen millions of antibodies from humanized mice, ...